Angioscopic evaluation of coronary atherosclerotic plaque after revascularization with drug-eluting stent - Intervention trial with statins and cholesterol absorption inhibitors
Not Applicable
- Conditions
- Ischemic heart disease
- Registration Number
- JPRN-UMIN000010347
- Lead Sponsor
- ippon Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients within 72 hr after the incidence of acute myocardial infarction. 2. Patients with marked stenosis in the main coronary artery 3. Patients with serum creatinine over 2.0mg/dL. 4. The patients with heart failure which is over NYHA cardiac function classification3, or ejection fraction is less than 40%. 5. The patients with secondary hypercholesterolemia 6. The patients who were daily treated with over 10mg of atorvastatin or 2mg of pitavastatin or 2.5mg of rosuvastatin, and the combination of ezetimibe and statin.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method